Nathalie C. B.
- Country
- France
- Department
- Gynecologie Obstetrique Medecine de la Reproduction
Research Overview
- Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients
- A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age with Moderate to Severe Endometriosis-related Pain
Data & Insights
Has run more than one trial at 8 of 113 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating patients with hormone-receptor positive breast cancer, with particular attention to managing treatment-related symptoms.
- Endocrine Therapy Management
- Breast Cancer Risk Assessment
- Therapeutic Symptom Control
The investigator focuses on advancing treatments for patients experiencing therapy-induced side effects.
Symptom Management
Expertise centers on addressing vasomotor symptoms that develop during cancer treatment, particularly focusing on therapeutic interventions for hot flashes.
- Treatment-Induced Side Effects
- Hot Flash Management
- Quality of Life Improvement
Their work emphasizes the development of targeted approaches for managing treatment-related vasomotor symptoms.
Preventive Medicine
The investigator works with patients who are at high risk for developing breast cancer, focusing on preventive care and symptom management strategies.
- Risk Factor Assessment
- Preventive Interventions
- Patient Monitoring
Their research includes evaluating new therapeutic options for high-risk patients undergoing preventive treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.